ARTICLE | Company News
Biomira, Biovector terminate deal
March 30, 2001 8:00 AM UTC
Biomira (BIOM; TSE:BRA) and Biovector Therapeutics (Toulouse, France) terminated a co-development deal for BIOM's idiotypic vaccine against B cell lymphoma. BIOM said the termination resulted from Bio...